Regulation of iron metabolism in the acute-phase response: Interferon γ and tumour necrosis factor α induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients

European Journal of Clinical Investigation

Volumn 28, Issue 7, 1998, Pages 520-527

  Feelders, R A ^a,b   Vreugdenhil, G ^c   Eggermont, A M M ^b   Kuiper Kramer, P A ^d   Van Eijk, H G ^a   Swaak, A J G ^e,f  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ST JOSEPH HOSPITAL   (Netherlands)

^d Sophia Hospital   (Netherlands)

^e CENTRAL LABORATORY   (Netherlands)

^f Zuiderziekenhuis   (Netherlands)

Author keywords

Acute phase response; Anaemia of chronic disease; Cytokines; Ferritin; Hypoferraemia; Serum transferrin receptor

Indexed keywords

ALBUMIN; CYTOKINE; FERRITIN; INTERLEUKIN 6; MELPHALAN; RECOMBINANT GAMMA INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CANCER; CLINICAL ARTICLE; FEMALE; HUMAN; IRON DEFICIENCY ANEMIA; IRON METABOLISM; LIMB PERFUSION; MALE; MELANOMA; PRIORITY JOURNAL; SARCOMA; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSFERRIN BLOOD LEVEL;

EID: 0031857792     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00323.x     Document Type: Article

References (61)

1. Kushner I. The phenomenon of the acute phase response. Ann NY Acad Sci 1982; 389: 39-48.
2. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15: 74-80.
3. Vilcek J, Le J. Immunology of cytokines: an introduction. In: Thomson AW, ed. The Cytokine Handbook. San Diego: Academic Press 1991: 2-17.
4. Le J, Vilcek J.. Biology of disease. Tumor necrosis factor and interleukin 1: Cytokines with multiple overlapping biological activities. Lab Invest 1987; 56: 234-48.
5. Dinarello CA.. Interleukin-1. In: Thomson AW, ed. The Cytokine Handbook. San Diego: Academic Press 1991; 47-82.
6. Tosato G, Jones KD. Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. Blood 1990; 75: 1305-10.
7. Jablons DM, Mule JJ, McIntosh JK, et al. IL-6/IFNβ2 as a circulating hormone. Induction by cytokine administration in humans. J Immunol 1989; 142: 1542-7.
8. McIntosh JK, Jablons DM, Mule JJ, et al. In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice. J Immunol 1989; 143: 162-7.
9. Le J, Vilcek J. Biology of disease. Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 1989; 61: 588-602.
10. Castell JV, Andus T, Kunz D, Heinrich PC. Interleukin-6. The major regulator of acute-phase protein synthesis in man and rat. Ann NY Acad Sci 1989; 557: 87-100.
11. Cash JM, Sears DA. The anemia of chronic disease: Spectrum of associated diseases in a series of unselected hospitalized patients. Am J Med 1989; 87: 638-44.
12. Cartwright GE. The anaemia of chronic disorders. Semin Hematol 1966; 3: 351-75.
13. Cartwright GE, Lee GR. The anemia of chronic disorders. Br J Haematol 1971; 21: 147-52.
14. Means RT, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992; 80: 1639-47.
15. Denz H, Huber P, Landmann R, Orth B, Wachter H, Fuchs D. Association between the activation of macrophages, changes of iron metabolism and the degree of anaemia in patients with malignant disorders. Eur J Hematol 1992; 48: 244-8.
16. Roodman GD. Mechanisms of erythroid suppression in the anemia of chronic disease. Blood Cells 1987; 13: 171-84.
17. Broxmeyer HE, Williams DE, Lu L, et al. The suppressive influences of tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: Synergism of tumor necrosis factor and interferon-γ. J Immunol 1986; 136: 4487-95.
18. Means RT, Dessypris EN, Krantz SB. Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon. J Cell Physiol 1992; 150: 59-64.
19. Baer AN, Dessypris EN, Goldwasser RE, Krantz SB. Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol 1987; 66: 559-64.
20. Freireich EJ, Miller A, Emerson CP, Ross JF. The effect of inflammation on the utilization of erythrocyte and transferrin bound radioiron for red cell production. Blood 1957; 12: 972-83.
21. Hershko C, Cook JD, Finch CA. Storage iron kinetics VI. The effect of inflammation on iron exchange in the rat. Br J Haematol 1974; 28: 67-75.
22. Lee GR. The anaemia of chronic disease. Semin Hematol 1983; 20: 61-80.
23. Kobune M, Kohgo Y, Kato J, Miyazaki E, Niitsu Y. Interleukin-6 enhances hepatic transform uptake and ferritin expression in rats. Hepatology 1994; 19: 1468-75.
24. 59Fe labeled dextran model. Ann Rheum Dis 1974; 13: 147-52.
25. Fillet G, Beguin Y, Baldelli L. Model of reticuloendothelial iron metabolism in humans: abnormal behaviour in idiopathic hemochromatosis and in inflammation. Blood 1989; 74: 844-51.
26. Konijn AM, Hershko C. Ferritin synthesis in inflammation I. Pathogenesis of impaired iron release. Br J Haematol 1977; 37: 7-16.
27. Elin RJ, Wolff SM, Finch CA. Effect of induced fever on serum iron and ferritin concentrations in man. Blood 1977; 49: 147-53.
28. Vreugdenhil G, Kroos MJ, van Eijk HG, Swaak AJG. Impaired iron uptake and transferrin binding by erythroblasts in the anaemia of rheumatoid arthritis. Br J Rheumatol 1990; 29: 335-9.
29. Moldawer LL, Marano MA, Wei HE, et al. Cachectin/tumor necrosis factor-α alters red blood cell kinetics and induces anemia in vivo. FASEB J 1989; 3: 1637-43.
30. Feelders RA, Vreugdenhil G, van Dijk JP, Swaak AJG, van Eijk HG. Decreased affinity and number of transferrin receptors on erythroblasts in the anemia of rheumatoid arthritis. Am J Hematol 1993; 43: 200-4.
31. Huebers HA, Beguin Y, Pootrakul P, Einspahr D, Finch CA. Intact transferrin receptors in human plasma and their relation to erythropoicsis. Blood 1990; 75: 102-7.
32. Kongo Y, Niitsu Y, Kondo H, et al. Serum transferrin receptor as a new index of erythropoiesis. Blood 1987; 70: 1955-8.
33. Feelders RA, Vreugdenhil G, Manger B, van Eijk HG, Swaak AJG. Serum transferrin receptor levels in anaemia of rheumatoid arthritis and effects of iron chelation treatment. Eur J Haematol 1994; 52: 61-2.
34. Ferguson BJ, Skikne BS, Simpson KM, Baynes RD, Cook JD. Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med 1992; 119: 385-90.
35. Tanaka T, Araki E, Nitta K, Tateno M. Recombinant human tumor necrosis factor depresses serum iron in mice. J Biol Response Mod 1987; 6: 484-8.
36. Uchida T, Yamagiwa A, Nakamura K. The effect of interleukin-1 on iron metabolism in rats. Eur J Haematol 1991; 46: 1-5.
37. Hirayama M, Kohgo Y, Kondo H, et al. Regulation of iron metabolism in HepG2 cells: a possible role for cytokines in the hepatic deposition of iron. Hepatology 1993; 18: 874-80.
38. Fahmy M, Young SP. Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA. Biochem J 1993; 296: 175-81.
39. Alvarez-Hernández X, Licéaga J, Mckay IC, Brock JH. Induction of hypoferraemia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest 1989; 61: 319-22.
40. Liénard D, Ewalenko P, Delmotte JJ, Renard N, Lejeune FJ. High dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolated perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 1992; 10: 52-60.
41. Eggermont AMM, Schraffordt Koops H, Liénard D, et al. Isolated Limb Perfusion with high dose tumor necrosis factor-α in combination with IFN-γ and melphalan for irresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol 1996; 14: 2653-65.
42. Eggermont AMM, Schraffordt Koops H, Klausner J, et al. Isolated Limb Perfusion with tumor necrosis factor-α and melphalan in 186 patients with locally advanced extremity sarcomas: the cumulative multicenter European experience. Ann Surg 1996; 224: 756-65.
43. Swaak AJG, Liénard D, Schraffordt Koops H, Lejeune FJ, Eggermont AMM. Effects of recombinant tumor necrosis factor (rTNF-α) in cancer. Observations on the acute phase protein reaction and immunoglobulin synthesis after high dose recombinant TNF-α administration in isolated limb perfusions in cancer patients. Eur J Clin Invest 1993; 23: 812-8.
44. van Kooten C, Rensink I, Pascual-Salcedo D, van Oers R, Aarden LA. Monokine production by human T cells; IL-1α production restricted to memory T-cells. J Immunol 1991; 146: 2654-8.
45. Helle M, Boeije L, de Groot ER, de Vos A, Aarden LA. Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera. J Immunol Methods 1991; 138: 47-56.
46. Kuiper-Kramer EPA, Huisman CMS, van Raan J, van Eijk HG. Analytical and clinical implications of soluble transferrin receptors in serum. Eur J Clin Chem Clin Biochem 1996; 34: 645-9.
47. Biesma DH, de Wiel A, Beguin Y, Kraaijenhagen RJ, Marx JJM. Post-operative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism. Eur J Clin Invest 1995; 25: 383-9.
48. Zwaveling JH, Maring JK, Clarke FL, et al. High plasma tumor necrosis factor (TNF)-α concentrations and a sepsis-like syndrome in patients undergoing hyperthermic isolated limb perfusion with recombinant TNF-α, interferon-γ, and melphalan. Crit Care Med 1996; 24: 765-70.
49. Kushner I, Rzewnicki DL. The acute phase response: General aspects. Baillière's Clin Rheumatol 1994; 8: 513-30.
50. Perlmutter DH, Dinarello CA, Punsal PI, Colten HR. Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest 1986; 78: 1349-54.
51. Baumann H, Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 1990; 7: 147-59.
52. Morrone G, Ciliberto G, Oliviero S, et al. Recombinant interleukin-6 regulates the transcriptional activation of a set of human acute phase genes. J Biol Chem 1988; 263: 12554-8.
53. Melefors Ö, Hentze MW. Iron regulatory factor. The conductor of cellular iron regulation. Blood Rev 1993; 7: 251-8.
54. Weiss G, Goossen B, Doppler W, et al. Translational regulation via iron responsive elements by the nitric oxide/ NO-synthase pathway. EMBO J 1993; 12: 3651-7.
55. Rogers JT, Bridges KR, Durmowicz GP, Glass J, Auron PE, Munro HN. Translational control during the acute phase response. J Biol Chem 1990; 265: 14572-8.
56. Miller LL, Miller SC, Torti SV, Tsuji Y, Torti FM. Iron-independent induction of ferritin H chain by tumor necrosis factor. Proc Nat Acad Sci USA 1991; 88: 4946-50.
57. Kwak EL, Larochelle DA, Beaumont C, Torti SV, Torti FM. Role for NFκB in the regulation of ferritin H by tumor necrosis factor alpha. J Biol Chem 1995; 270: 15285-93.
58. Weinberg ED. Iron, infection and neoplasia. Clin Physiol Biochem 1986; 4: 50-60.
59. Kuiper-Kramer PA, Huisman CMS, van der Molen-Sinke J, Abbes A, Eijk HG van. The expression of transferrin receptors on erythroblasts in anaemia of chronic disease, myelodysplastic syndromes and iron deficiency. Acta Haematol 1997; 97: 127-31.
60. Vadhan-Raj S, Al-Katib A, Bhulla R, et al. Phase I trial of recombinant interferon gamma in cancer patients. J Clin Oncol 1986; 4: 137-46.
61. Blick M, Sherwin SA, Rosenblum M, Gutterman J. Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res 1987; 47: 2986-9.